Prognostic value of the quantified expression of p185c-erbb2 in non–small cell lung cancer
- 30 June 2000
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 119 (6) , 1119-1125
- https://doi.org/10.1067/mtc.2000.105211
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Revisions in the International System for Staging Lung CancerChest, 1997
- Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissueBritish Journal of Cancer, 1997
- Prognostic Value of Flow Cytometric DNA Analysis in Non‐Small‐Cell Lung Cancer: Rationale of Sequential Processing of Frozen and Paraffin‐Embedded TissueWorld Journal of Surgery, 1997
- Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast CancerAnnals of Surgery, 1994
- Assay of the c-erbB-2 Oncogene Encoded Protein by ELISA and Immunocytochemistry in Human Breast CancerAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994
- The future of prognostic factors in outcome prediction for patients with cancerCancer, 1992
- Nonparametric Estimation from Incomplete ObservationsPublished by Springer Nature ,1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Carcinoma of the Lung: Evaluation of Histological Grade and Factors Influencing PrognosisThe Annals of Thoracic Surgery, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981